Chip Drug development
organ compartments
multi-organ
chip device
chip technologies
development applications
cost of drug development
Multi-compartmental Organ
preclinical testing platform
pharmaceutical development pipeline
multi-compartment microfluidic platform
therapeutic validation
preclinical work
animal testing
animal studies
innovation gap
future therapeutic assessment
endothelialized-conduit system
vascular-similar conduit system
large implications
recalled drugs
preliminary human
throughput of therapeutics
early stage human
long term implications
needs
accordance
synthetic biointeractive hydrogels
high experimental costs
failures
delays
complexities
potential
times
results
quicker turn
reliance
generation tools
functions
guidelines
process
market
animals
quality of life
heart
humans
economic burden
project
years
Successful production
liver
efficiency
staggering expenses